Home  >  Health Check  >  A new era for Alzheimer’s drugs?
Health Check
A new era for Alzheimer’s drugs?
Health Check
Jul 19, 2023

Just months after the ‘momentous’ announcement of the first drug shown to slow the effects of Alzheimer’s disease, the results of a global trial into another have been published. The antibody medicine donanemab helped people in the early stages of Alzheimer’s by slowing the pace of the brain’s decline by about a third. Dr Graham Easton joins Claudia Hammond to look at what another ‘breakthrough’ means in practice.

They also look at new evidence from the USA that giving hearing aids to older people at risk from dementia could be another way to slow cognitive decline in some people.

While caring for women in childbirth, midwives are expected to be compassionate. Claudia hears from Dr Halima Musa Abdul, Senior Lecturer in Nursing Science at Ahmadu Bello University in Nigeria, and to Dr Kaveri Mayra, who trained in India and is now a researcher at the University of British Columbia. They say that particularly in lower and middle income countries, midwives aren’t being shown enough compassion at work themselves.

And we hear from Germany where a portable brain scanner could provide a solution for people in hard-to-reach health clinics.

Image Credit: Andrew Brookes

Presenter: Claudia Hammond Producer: Clare Salisbury & Dan Welsh

More Episodes



Apr 22, 2026
Making surgery safer for infants

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.

Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.

We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.

We’re joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.

And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

A new era for Alzheimer’s drugs?

--:--
--:--